Amgen and Allergan win FDA nod for biosimilar of Avastin, Roche's $3B seller
admin 14th September 2017 Uncategorised 0The FDA has ushered in a new era in lower cost cancer medicines with its approval of Amgen’s Mvasi, a biosimilar of Roche’s blockbuster drug Avastin.
More: Amgen and Allergan win FDA nod for biosimilar of Avastin, Roche's B seller
Source: fierce